Bristol-Myers Squibb Co (BMY)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

$61.57

Buy

$62.00

arrow-down$-0.03 (-0.05%)

Prices updated at 02 Mar 2026, 12:00 EST

Prices minimum 15 mins delay

Prices in USD

Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals.

S&P 500

0.04%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2024	2025
	48,300m	48,195m
	34,332m	34,259m
	5,887m	13,724m
	12.19	28.48
	-8,948m	7,054m
	3,168m	15,230m
Sales, General and administrative	8,414m	7,267m
Interest expenses	1,947m	1,891m
Provision for income taxes	554m	2,272m
Operating expenses	28,445m	20,535m
Income before taxes	-8,379m	9,328m
Net income available to common shareholders	-8,948m	7,054m
	-4.41	3.47
Net interest income	-1,947m	-1,891m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	-4.41	3.46
Free cash flow per share	6.8071	7.5129
Book value/share	8.4485	9.1131
Debt equity ratio	2.998041	2.418449

Balance sheet

Year chevron-l-regular chevron-r-regular	2024	2025
Current assets	29,780m	29,390m
Current liabilities	23,774m	23,417m
Total capital	63,938m	61,323m
Total debt	51,200m	47,139m
Total equity	16,335m	18,473m
Total non current liabilities	-	-
Loans	47,603m	42,850m
Total assets	92,603m	90,038m
Total liabilities	-	-
Cash and cash equivalents	10,346m	10,209m
Common stock	2,029m	2,036m

Cash flow

Year chevron-l-regular chevron-r-regular	2024	2025
Cash at beginning of period	11,519m	10,347m
Cash dividends paid	-4,863m	-5,045m
	13,942m	12,845m
Investments (gains) losses	-21,352m	-4,132m
	10,347m	10,218m
Net income	-	-
	15,190m	14,156m
	-1,248m	-1,311m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.